Jenna Sopfe, Laura Pyle, Amy K Keating, Kristen Campbell, Arthur K Liu, R Paul Wadwa, Michael R Verneris, Roger H Giller, Gregory P Forlenza
Malglycemia (hypoglycemia, hyperglycemia, and/or glycemic variability) in adult hematopoietic stem cell transplant (HSCT) recipients is associated with increased infection, graft-versus-host disease, organ dysfunction, delayed engraftment, and mortality. Malglycemia has not been studied in pediatric HSCT recipients. This study aimed to characterize the incidence and consequences of malglycemia in this population. Medical records for a cohort of 344 patients, age 0 to 30 years, who underwent first HSCT from 2007 to 2016 at Children's Hospital Colorado were retrospectively reviewed...
February 12, 2019: Blood Advances